BioSpace News Archive

Biotech Beach

ALASTIN Skincare® Unveils Breakthrough Product: TransFORM Body Treatment with TriHex Technology® At American Society for Dermatologic Surgery (ASDS) Meeting

Unique Peptide and Liposome Delivery Technology Help Accelerate Body Sculpting Results, Enhance Skin Tightening Treatment Outcomes & Improve Skin Crepiness

October 9, 2018
·
4 min read
Pharm Country

Topix Pharmaceuticals, Inc. Launches Backbar Line

Physicians Can Now Use Their Own Branding On A Targeted Treatment Regimen

October 9, 2018
·
2 min read
Concordia International Corp. Announces Intention To Rebrand As ADVANZ PHARMA Following Its Successful Recapitalization

ADVANZ PHARMA represents the Company’s vision to go beyond expectations to bring sustainable value to customers, healthcare providers, and patients

October 9, 2018
·
7 min read
Business

Ablexis Announces Licensing Agreement with Memorial Sloan Kettering Cancer Center

Grants rights to research, develop and commercialize antibodies generated using the AlivaMab Mouse Platform

October 9, 2018
·
2 min read
Business

Variant Pharmaceuticals Enhances Its Board of Directors with Three New Members

Robert (Rob) G. Finizio: Chief Executive Officer, Co-Founder, and Director of TherapeuticsMD Inc

October 9, 2018
·
3 min read
Business

Keen Eye and Iris Pharma Team up to Bring Artificial Intelligence in Ophthalmology Studies

Keen Eye announced today a strategic partnership agreement with Iris Pharma, a world-wide leading ophthalmology-focused contract research organization (CRO) that offers preclinical and clinical drug / device development services.

October 9, 2018
·
2 min read
Business

ProAssurance Corporation Announces Dates for Third Quarter 2018 Earnings Release and Conference Call

ProAssurance Corporation will report results for the nine months and quarter ended September 30, 2018 after the close of normal New York Stock Exchange trading on Tuesday, November 6, 2018.

October 9, 2018
·
1 min read
Drug Development

Incyte Announces Data for Pemigatinib, its Selective FGFR Inhibitor, to be Featured at the ESMO 2018 Congress

Interim Phase 2 results highlight the potential of pemigatinib (INCB54828) in cholangiocarcinoma and urothelial carcinoma.

October 9, 2018
·
5 min read
Biotech Beach

Dr. Sanusi Umar Releases Advanced Hair Transplant Technology, Disrupts Industry

After a number of delays in production, a promising new hair transplant technology has been made available to all hair transplant providers.

October 9, 2018
·
3 min read
Pharm Country

Big Fish, Big Data and Blood Banks: Ortho Clinical Diagnostics to Demonstrate Comprehensive Middleware Solution, Host Customer Event at New England Aquarium During the 2018 AABB Annual Meeting

Customer Event to Highlight How Access to Information and Advances in Automation Can Improve Transfusion Medicine Operations

October 9, 2018
·
3 min read